News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Adjuvant Global Health Technology Fund, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Adjuvant Global Health Technology Fund, L.P. (10% Owner) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Sold 83,337 shares
@ $16.28, valued at
$1.4M
Sold 15,764 shares
@ $16.28, valued at
$256.6k
Sold 4,770 shares
@ $16.07, valued at
$76.7k
Sold 902 shares
@ $16.07, valued at
$14.5k
|
|
| 09/29/2023 |
4
| Adjuvant Global Health Technology Fund, L.P. (10% Owner) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Sold 707 shares
@ $16.07, valued at
$11.4k
Sold 134 shares
@ $16.07, valued at
$2.2k
Sold 7,160 shares
@ $16.11, valued at
$115.3k
Sold 1,356 shares
@ $16.11, valued at
$21.8k
|
|
| 08/25/2023 |
4
| Adjuvant Global Health Technology Fund, L.P. (10% Owner) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Sold 336 shares
@ $16, valued at
$5.4k
Sold 64 shares
@ $16, valued at
$1k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/24/2022 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 03/31/2022 |
4
| Adjuvant Global Health Technology Fund, L.P. (10% Owner) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Converted 1,651,636 shares
@ $0
Converted 312,415 shares
@ $0
Converted 392,433 shares
@ $0
Converted 74,230 shares
@ $0
Bought 166,666 shares
@ $15, valued at
$2.5M
Converted 1,651,636 convertible preferred
@ $0
Converted 312,415 convertible preferred
@ $0
Converted 392,433 convertible preferred
@ $0
Converted 74,230 convertible preferred
@ $0 |
|
| 03/24/2022 |
3
| Adjuvant Global Health Technology Fund, L.P. (10% Owner) has filed a Form 3 on AN2 Therapeutics, Inc. |
|
|